| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8236717 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 6 Pages |
Abstract
Age at irradiation and time since therapy appear to be the only significant risk factors for development of BC after treatment of HL. The risk is significantly higher 15 years or more after radiation and for women treated before age 30 years. Long-term surveillance strategies are indicated for women at risk.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Mohamed A. M.D., Kevin S. M.D., Dianne M. Ph.D., Keith A. M.A., Torunn I. M.D., Nancy J. M.D., Alan C. M.D., Ph.D., Alphonse G. M.D., Ph.D.,